Insurances & Business
News Economy Business Investment Banks Credits
Archive April/2008
Shares of aluminum producers struggled for direction Tuesday as investors assessed whether industry leader Alcoa Inc.'s first-quarter profit miss reflects on the entire sector.
Jim Rogers: More Pain for the Greenback, and the Failure of the Federal Reserve (Business Wire)
SINGAPORE----The following are highlights from an interview by Keith Fitz-Gerald, Investment Director, Money Morning/The Money Map Report:
Sector Snap: Oil Services Firms Fall (AP)
Oilfield-services stocks were down slightly Tuesday, along with oil prices, despite a Calyon Securities analyst issuing a positive outlook and lifting 12 stocks' price targets.
Ore. Guv Willing to Sue on LNG Ports (AP)
Gov. Ted Kulongoski said he is willing to go to court to make sure any liquefied natural gas facilities slated for Oregon are needed and safe.
Evergreen Mountain Four Season Resort Announces Pat LaMarche As Spokesperson (Business Wire)
PORTLAND, maine----Seth Carey the author of the Evergreen Mountain Four Season Resort Casino referendum announced today that Pat LaMarche has been named the spokesperson for the campaign.
Navajos Appeal Pipeline Tariffs Order (AP)
The Navajo Nation has appealed the federal government's acceptance of rates set by Western Refining Pipeline Co. to ship crude oil on the company's pipeline, saying the rates are discriminatory
Research and Markets: Genzyme IMS Company Profile Gives You an Authoritative Insight into the Company at a Strategic and Local Level (Business Wire)
DUBLIN, Ireland----Research and Markets has announced the addition of Genzyme IMS Company Profile to their offering.
Sector Snap: Gold Miners Slide (AP)
Shares of gold mining companies fell Tuesday as the price of the metal declined and the International Monetary Fund said it will sell some of its reserves.
Ex-NYMEX Director Pleads Guilty to Fraud
NEW YORK (Reuters) - A floor trader who served on the board of the New York Mercantile Exchange <NMX.N> agreed to serve five months in prison on Tuesday after pleading
FDA Says Glaxo Failed to Report Avandia Data
WASHINGTON (Reuters) - GlaxoSmithKline Plc <GSK.L> <GSK.N> failed to report all of the required post-approval data on its diabetes drug Avandia to U.S. regulators, the Food and Drug Administration said
